148 related articles for article (PubMed ID: 24939198)
1. Developing a hand-held Pap test card to improve cervical cancer screening.
Prendergast MB; Hunter LP
Nurs Womens Health; 2014; 18(3):212-9. PubMed ID: 24939198
[TBL] [Abstract][Full Text] [Related]
2. Attitudes toward cervical cancer screening among women receiving human papillomavirus vaccination in a university-hospital-based community: interim 2-year follow-up results.
Miyagi E; Sukegawa A; Motoki Y; Kaneko T; Maruyama Y; Asai-Sato M; Numazaki R; Mizushima S; Hirahara F
J Obstet Gynaecol Res; 2014 Apr; 40(4):1105-13. PubMed ID: 24428631
[TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness of two outreach strategies for cervical cancer screening.
Bowles EJ; Gao H; Brandzel S; Bradford SC; Buist DS
Prev Med; 2016 May; 86():19-27. PubMed ID: 26820221
[TBL] [Abstract][Full Text] [Related]
4. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
[TBL] [Abstract][Full Text] [Related]
5. Impact of Patient Reminders on Papanicolaou Test Completion for High-Risk Patients Identified by a Clinical Decision Support System.
MacLaughlin KL; Kessler ME; Komandur Elayavilli R; Hickey BC; Scheitel MR; Wagholikar KB; Liu H; Kremers WK; Chaudhry R
J Womens Health (Larchmt); 2018 May; 27(5):569-574. PubMed ID: 29297754
[TBL] [Abstract][Full Text] [Related]
6. Development of mobile technologies for the prevention of cervical cancer in Santiago, Chile study protocol: a randomized controlled trial.
Momany MC; Martinez-Gutierrez J; Soto M; Capurro D; Ciampi F; Thompson B; Puschel K
BMC Cancer; 2017 Dec; 17(1):847. PubMed ID: 29237420
[TBL] [Abstract][Full Text] [Related]
7. Challenges in cervical cancer prevention: a survey of U.S. obstetrician-gynecologists.
Perkins RB; Anderson BL; Gorin SS; Schulkin JA
Am J Prev Med; 2013 Aug; 45(2):175-81. PubMed ID: 23867024
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer in developing countries: effective screening and preventive strategies with an application in Rwanda.
Mukakalisa I; Bindler R; Allen C; Dotson J
Health Care Women Int; 2014; 35(7-9):1065-80. PubMed ID: 24750113
[TBL] [Abstract][Full Text] [Related]
9. Pap test adherence, cervical cancer perceptions, and HPV knowledge among HIV-infected women in a community health setting.
Lambert CC; Chandler R; McMillan S; Kromrey J; Johnson-Mallard V; Kurtyka D
J Assoc Nurses AIDS Care; 2015; 26(3):271-80. PubMed ID: 25769754
[TBL] [Abstract][Full Text] [Related]
10. A Community-Academic Partnership to Increase Pap Testing in Appalachian Kentucky.
Collins T; Stradtman LR; Vanderpool RC; Neace DR; Cooper KD
Am J Prev Med; 2015 Aug; 49(2):324-30. PubMed ID: 26190807
[TBL] [Abstract][Full Text] [Related]
11. Implementing targeted cervical cancer screening videos at the point of care.
Montealegre JR; Gossey JT; Anderson ML; Chenier RS; Chauca G; Rustveld LO; Jibaja-Weiss ML
Patient Educ Couns; 2014 Dec; 97(3):426-9. PubMed ID: 25269411
[TBL] [Abstract][Full Text] [Related]
12. Cervical Cancer Screening for Women Living with HIV.
Chapman CL; Harris AL
Nurs Womens Health; 2016; 20(4):392-8. PubMed ID: 27520603
[TBL] [Abstract][Full Text] [Related]
13. A team care model of cervical
screening in a general practice.
Rennie D; Boxsell J; Pedretti K
Aust Fam Physician; 2015 Jul; 44(7):515-8. PubMed ID: 26590499
[TBL] [Abstract][Full Text] [Related]
14. The Annual Gynecologic Examination Updated for the 21st Century.
Cappiello J; Levi A
Nurs Womens Health; 2016; 20(3):315-9. PubMed ID: 27287359
[TBL] [Abstract][Full Text] [Related]
15. Pap Testing in a High-Income Country with Suboptimal Compliance Levels: A Survey on Acceptance Factors among Sicilian Women.
Restivo V; Costantino C; Marras A; Napoli G; Scelfo S; Scuderi T; Casuccio A; Cernigliaro A; Giusti A; Spila Alegiani S
Int J Environ Res Public Health; 2018 Aug; 15(9):. PubMed ID: 30131461
[TBL] [Abstract][Full Text] [Related]
16. Cervical cancer screening: a prospective cohort study of the effects of historical patient compliance and a population-based informatics prompted reminder on screening rates.
MacLaughlin KL; Swanson KM; Naessens JM; Angstman KB; Chaudhry R
J Eval Clin Pract; 2014 Apr; 20(2):136-43. PubMed ID: 24237657
[TBL] [Abstract][Full Text] [Related]
17. The impact of level of education on adherence to breast and cervical cancer screening: Evidence from a systematic review and meta-analysis.
Damiani G; Basso D; Acampora A; Bianchi CB; Silvestrini G; Frisicale EM; Sassi F; Ricciardi W
Prev Med; 2015 Dec; 81():281-9. PubMed ID: 26408405
[TBL] [Abstract][Full Text] [Related]
18. Chronic comorbidities and cervical cancer screening and adherence among US-born and foreign-born women.
Cofie LE; Hirth JM; Wong R
Cancer Causes Control; 2018 Nov; 29(11):1105-1113. PubMed ID: 30353481
[TBL] [Abstract][Full Text] [Related]
19. Study points to value of HPV screening for cervical cancer: test may be viable alternative to Pap test.
Printz C
Cancer; 2014 Dec; 120(23):3589-90. PubMed ID: 25410486
[No Abstract] [Full Text] [Related]
20. Squamous cell carcinoma of the cervix: a cytology-histology-human papillomavirus correlation in clinical practice.
Miller RA; Waters LL; Mody DR; Tams KC
Arch Pathol Lab Med; 2015 Jun; 139(6):776-81. PubMed ID: 26030246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
